In NAFLD&CRA patients, TM6SF2 rs58542926 T allele also tightly associated with the abnormal regulation of lipids metabolism and liver injury, and the presence of CRA aggravates the clinical performance of NAFLD. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.